Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Quadrivalent Influenza Vaccine (QIV) vs Trivalent Influenza Vaccines (TIV) in Adults and Elderly
2011-001976-21Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of influenza vaccine in influenza (3 arms), sponsored by Sanofi. Primary endpoint: Primary immunogenicity endpoint. Started Jul 2011; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2011-001976-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001976-21.